Remove 2024 Remove Drug Development Remove Health Technology Remove Pharmaceuticals
article thumbnail

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Digital Health Global

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Drug Discovery and Early Development Outsourcing Services” report has been added to ResearchAndMarkets.com’s offering. hike over 2022, with more than 6,100 molecules in active development. growth between 2023 to 2024.